EASD 2024

Sales & Marketing

This September, Madrid played host to the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD).

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.